Orexigen Bankruptcy Shows Difficulty of Marketing Weight-Loss Drugs

Drugmaker Orexigen filed for bankruptcy protection on Monday and plans to sell itself, after failing to find a profitable market for its weight-loss treatment Contrave....

5 Published By - WSJ.com: US Business - 2018.03.12. 21:23
Share |